https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct06267001-2026-06-10 Hipa.ai en 2026-06-10T00:00:00.000Z Atezolizumab NSCLC Trial Terminated; Adverse Event Counts Posted https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04879368-2026-06-10 Hipa.ai en 2026-06-10T00:00:00.000Z Nivolumab (RegoNivo) Misses OS Endpoint in Advanced Gastro-Oesophageal Cancer